Israel Englander Mei Pharma, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.21 - $0.35 $43,790 - $72,984	-208,526 Reduced 60.74%	134,760 $31,000
Q4 2022 Feb 14, 2023	SELL	$0.22 - $8.4 $84,000 - $3.21 Million	-381,820 Reduced 52.66%	343,286 $84,000
Q3 2022 Nov 14, 2022	SELL	$0.41 - $8.8 $264,675 - $5.68 Million	-645,550 Reduced 47.1%	725,106 $280,000
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.65 $575,675 - $890,926	1,370,656 New	1,370,656 $829,000
Q1 2022 May 16, 2022	SELL	$0.54 - $2.74 $54,486 - $276,466	-100,900 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.33 - $3.37 $883,358 - $1.28 Million	-379,124 Reduced 78.98%	100,900 $269,000
Q3 2021 Nov 15, 2021	SELL	$2.52 - $2.99 $315,471 - $374,309	-125,187 Reduced 20.68%	480,024 $1.33 Million
Q2 2021 Aug 16, 2021	BUY	$2.6 - $3.65 $526,554 - $739,201	202,521 Added 50.29%	605,211 $1.73 Million
Q1 2021 May 17, 2021	SELL	$2.73 - $4.5 $706,584 - $1.16 Million	-258,822 Reduced 39.13%	402,690 $1.38 Million
Q4 2020 Feb 16, 2021	SELL	$2.6 - $3.32 $900,265 - $1.15 Million	-346,256 Reduced 34.36%	661,512 $1.75 Million
Q3 2020 Nov 16, 2020	SELL	$2.46 - $4.27 $386,146 - $670,261	-156,970 Reduced 13.48%	1,007,768 $3.14 Million
Q2 2020 Aug 14, 2020	BUY	$1.45 - $4.3 $872,070 - $2.59 Million	601,428 Added 106.77%	1,164,738 $4.81 Million
Q1 2020 May 14, 2020	SELL	$0.75 - $2.55 $94,529 - $321,399	-126,039 Reduced 18.28%	563,310 $907,000
Q4 2019 Feb 14, 2020	SELL	$1.65 - $2.48 $1.27 Million - $1.91 Million	-768,436 Reduced 52.71%	689,349 $1.71 Million
Q3 2019 Nov 14, 2019	SELL	$1.48 - $2.52 $195,812 - $333,411	-132,306 Reduced 8.32%	1,457,785 $2.45 Million
Q2 2019 Aug 15, 2019	BUY	$2.45 - $3.32 $3.46 Million - $4.69 Million	1,411,830 Added 792.0%	1,590,091 $3.98 Million
Q2 2019 Aug 14, 2019	SELL	$2.45 - $3.32 $1.26 Million - $1.71 Million	-514,872 Reduced 74.28%	178,261 $403,000
Q1 2019 May 14, 2019	BUY	$2.52 - $3.24 $1.24 Million - $1.59 Million	491,548 Added 243.84%	693,133 $2.13 Million
Q4 2018 Feb 14, 2019	SELL	$1.92 - $4.1 $2.64 Million - $5.63 Million	-1,373,093 Reduced 87.2%	201,585 $532,000
Q3 2018 Nov 14, 2018	BUY	$3.39 - $4.61 $609,820 - $829,283	179,888 Added 12.9%	1,574,678 $6.79 Million
Q2 2018 Aug 14, 2018	BUY	$1.89 - $4.95 $2.62 Million - $6.85 Million	1,384,237 Added 13117.0%	1,394,790 $5.5 Million
Q1 2018 May 15, 2018	BUY	$2.06 - $2.38 $21,739 - $25,116	10,553 New	10,553 $22,000
Q4 2017 Feb 14, 2018	SELL	$1.91 - $2.83 $97,929 - $145,099	-51,272 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.44 - $2.91 $125,103 - $149,201	51,272	51,272 $137,000

Others Institutions Holding MEIP

# of Institutions

Shares Held

Call Options Held

Put Options Held

Urban Wealth Management, LLC

2K
Shares

$5,777
0.0% of portfolio

View Full List

About MEI Pharma, Inc.

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

More about MEIP

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account